Related Experiment Video

Updated: Mar 2, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.8K

The Complexity of DEK Signaling in Cancer Progression

Yong Teng1, Liwei Lang1, Catherine E Jauregui1

  • 1Department of Oral Biology, Dental College of Georgia, Augusta University, Augusta, Georgia, United States.

Current Cancer Drug Targets
|May 23, 2017
PubMed

Insights

The DEK protein regulates cell functions and is key in cancer development. Research reviews DEK

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • DEK is a DNA-binding protein and chromatin regulator involved in cellular processes like proliferation, differentiation, and DNA repair.
  • DEK plays a critical role in cancer initiation and progression, with its activity tightly controlled by various factors.
  • DEK functions as an architectural protein, modulating gene expression and function in cancer cells.

Purpose of the Study:

  • To review the specificities and complexities of DEK in regulating transcription factors and global chromatin.
  • To summarize current research on the biological roles of DEK in malignant cells.
  • To discuss the potential of DEK as a diagnostic marker and therapeutic target for tumors.

Main Methods:

  • Literature review of existing research on DEK.
  • Analysis of DEK's role in gene expression and chromatin structure.
  • Synthesis of data on DEK's involvement in cancer biology.

Main Results:

  • DEK influences multiple cellular processes essential for normal cell function.
  • DEK's dysregulation is implicated in various stages of cancer development.
  • DEK's function involves intricate regulation of transcription factors and chromatin organization.

Conclusions:

  • DEK is a significant regulator of cellular processes and a key player in oncogenesis.
  • Understanding DEK's complex roles provides insights into cancer mechanisms.
  • DEK holds promise as a potential biomarker and therapeutic target for cancer treatment.
Keywords:
DEKbiologic rolescancerdiagnostic markerdrug targetgene regulations.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.3K
CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

3.2K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
8.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K